A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006)
- Conditions
- Interventions
- First Posted Date
- 2012-06-07
- Last Posted Date
- 2019-01-08
- Lead Sponsor
- Allergan
- Target Recruit Count
- 834
- Registration Number
- NCT01613248
Long-Term Patient Satisfaction of Facial Aesthetic Treatment With BOTOX®
- First Posted Date
- 2012-05-31
- Last Posted Date
- 2019-04-16
- Lead Sponsor
- Allergan
- Target Recruit Count
- 207
- Registration Number
- NCT01608672
An Observational Retrospective Study to Evaluate Treatment Patterns of Botulinum Toxin Type A
- First Posted Date
- 2012-05-31
- Last Posted Date
- 2019-04-17
- Lead Sponsor
- Allergan
- Target Recruit Count
- 110
- Registration Number
- NCT01608659
A Safety and Efficacy Study of a Dexamethasone Drug Delivery System for Postoperative Inflammation and Pain After Cataract Surgery
- Conditions
- Interventions
- First Posted Date
- 2012-05-25
- Last Posted Date
- 2015-07-01
- Lead Sponsor
- Allergan
- Target Recruit Count
- 8
- Registration Number
- NCT01605942
BOTOX® Treatment in Pediatric Lower Limb Spasticity
- Conditions
- Interventions
- First Posted Date
- 2012-05-22
- Last Posted Date
- 2018-08-14
- Lead Sponsor
- Allergan
- Target Recruit Count
- 384
- Registration Number
- NCT01603628
- Locations
- 🇺🇸
Harrison Clinical Management, Pomona, California, United States
🇺🇸AMS Neurology, Pasadena, California, United States
🇺🇸Children's Healthcare of Atlanta Children's Rehabilitation Associates, Atlanta, Georgia, United States
BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity
- Conditions
- Interventions
- First Posted Date
- 2012-05-22
- Last Posted Date
- 2019-08-21
- Lead Sponsor
- Allergan
- Target Recruit Count
- 220
- Registration Number
- NCT01603615
- Locations
- 🇺🇸
ABS Health, LLC, Pasadena, California, United States
🇺🇸Harrison Clinical Management, Pomona, California, United States
🇺🇸Rady Children's Hospital San Diego, San Diego, California, United States
BOTOX® Treatment in Pediatric Upper Limb Spasticity
- Conditions
- Interventions
- First Posted Date
- 2012-05-22
- Last Posted Date
- 2018-08-14
- Lead Sponsor
- Allergan
- Target Recruit Count
- 235
- Registration Number
- NCT01603602
- Locations
- 🇺🇸
Gillette Children's Specialty Healthcare, Saint Paul, Minnesota, United States
🇵🇱NZOZ Mazowieckie Centrum, Warsaw, Poland
🇹🇭Srinagarind Hospital, Khon Kaen University, Khon Kaen, Thailand
BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity
- Conditions
- Interventions
- First Posted Date
- 2012-05-22
- Last Posted Date
- 2019-08-21
- Lead Sponsor
- Allergan
- Target Recruit Count
- 370
- Registration Number
- NCT01603641
- Locations
- 🇺🇸
The Children's Mercy Hospital, Kansas City, Missouri, United States
🇵🇭St. Luke's Medical Center, Quezon City, Philippines
🇵🇱Uniwersytecki Dzieciecy Szpita, Białystok, Poland
Reliability of the Facial Wrinkle Scale in Japanese Subjects
- First Posted Date
- 2012-05-17
- Last Posted Date
- 2013-09-30
- Lead Sponsor
- Allergan
- Target Recruit Count
- 66
- Registration Number
- NCT01600729
Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS)
- Conditions
- Interventions
- First Posted Date
- 2012-05-17
- Last Posted Date
- 2019-04-30
- Lead Sponsor
- Allergan
- Target Recruit Count
- 144
- Registration Number
- NCT01600716